A business portfolio centered on functional chemicals, life sciences and specialty pharmaceuticals
First written in FY2016. 20 of 28 entries say "Restated". Latest entry: FY2025.
No other company in this theme has enough history to compare yet.
- FY2025Update to the number of companies in the corporate groupAnnual report
「The corporate group comprises the company, 30 subsidiaries, including 13 overseas subsidiaries, and 9 affiliates, including 4 overseas affiliates. It primarily conducts businesses related to functional chemicals, pharmaceuticals, medical care and health, and explosives, as well as other business activities including transportation and real estate.」
The core businesses remain unchanged. The corporate group is now described as comprising 30 subsidiaries, 9 affiliates and 4 overseas affiliates. - FY2024ReframedAnnual report
「From the current consolidated fiscal year, the reportable segment formerly presented as the “life sciences business” has been renamed the “pharmaceuticals, medical care and health business.”」
While the core business activities remain unchanged, the life sciences business was renamed the pharmaceuticals, medical care and health business, and NOF EUROPE GmbH was reclassified into that business. The corporate group comprises 31 subsidiaries and 5 affiliates. - FY2024-Q2RestatedAnnual report
「The names and classification methods of the reportable segments have been changed from the first quarter of the current consolidated fiscal year. Details are provided under “II. Cumulative Second Quarter of the Current Consolidated Fiscal Year,” “2. Matters Concerning Changes to Reportable Segments and Other Matters,” and “Segment Information” in “Chapter 4. Financial Information, 1. Quarterly Consolidated Financial Statements, Notes (Segment Information and Other Matters), Segment Information.”」
While there have been no material changes in the core business activities, the changes to the names and classifications of the reportable segments introduced in the previous quarter continue to be applied. - FY2024-Q1ReframedAnnual report
「There were no material changes in the businesses conducted by the group, comprising the company and its affiliates, during the cumulative first quarter of the current consolidated fiscal year. There were also no changes among the principal affiliates. The names and classification methods of the reportable segments were changed during the first quarter of the current consolidated fiscal year.」
While there were no material changes in the core business activities, the company changed the names and classification methods of its reportable segments. The life sciences business was renamed the pharmaceuticals, medical care and health business, and NOF EUROPE GmbH was reclassified into that business. - FY2023-Q3RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Group, comprising the Company and its affiliated companies, during the cumulative third quarter under review. There were also no changes among the principal affiliated companies.」
There have been no material changes in the business portfolio centered on functional chemicals, life sciences and explosives. - FY2023-Q2RestatedAnnual report
「There were no material changes in the businesses conducted by the group, comprising the company and its affiliates, during the cumulative second quarter of the current consolidated fiscal year. There were also no changes among the principal affiliates.」
There have been no material changes in the business portfolio centered on functional chemicals, life sciences and explosives, or in the number of principal affiliates. - FY2023-Q1RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Group, comprising the Company and its affiliated companies, during the cumulative first quarter under review. There were also no changes among the principal affiliated companies.」
The company states that there have been no material changes in its business portfolio centered on functional chemicals, life sciences and explosives, or in its principal affiliates. - FY2022-Q3RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Group, comprising the Company and its affiliated companies, during the cumulative third quarter under review. There were also no changes among the principal affiliated companies.」
There have been no material changes in the business portfolio centered on functional chemicals, life sciences and explosives, or in the number of principal affiliates. - FY2022-Q1RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Group, comprising the Company and its affiliated companies, during the cumulative first quarter under review. There were also no changes among the principal affiliated companies.」
There have been no material changes in the business portfolio centered on functional chemicals, life sciences and explosives, or in the number of principal affiliates. - FY2021RestatedAnnual report
「The corporate group comprises the company, 32 subsidiaries, including 13 overseas subsidiaries, and 5 affiliates, none of which are overseas affiliates. It primarily conducts businesses related to functional chemicals, life sciences and explosives, as well as other business activities including transportation and real estate.」
There have been no material changes in the business portfolio centered on functional chemicals, life sciences and explosives. - FY2021-Q3RestatedAnnual report
「There were no material changes in the businesses conducted by the group, comprising the company and its affiliates, during the cumulative third quarter of the current consolidated fiscal year. There were also no changes among the principal affiliates. 恩欧富塗料商貿(上海)有限公司, which had been an unconsolidated subsidiary through the previous consolidated fiscal year, has been included in the scope of consolidation from the first quarter of the current consolidated fiscal year because its materiality has increased.」
There have been no material changes in the business portfolio centered on functional chemicals, life sciences and explosives. The addition of 恩欧富塗料商貿(上海)有限公司 to the scope of consolidation continues to be disclosed. - FY2021-Q2RestatedAnnual report
「There were no material changes in the businesses conducted by the group, comprising the company and its affiliates, during the cumulative second quarter of the current consolidated fiscal year. There were also no changes among the principal affiliates. 恩欧富塗料商貿(上海)有限公司, which had been an unconsolidated subsidiary through the previous consolidated fiscal year, has been included in the scope of consolidation from the first quarter of the current consolidated fiscal year because its materiality has increased.」
There have been no material changes in the business portfolio centered on functional chemicals, life sciences and explosives. The addition of 恩欧富塗料商貿(上海)有限公司 to the scope of consolidation has continued since the first quarter. - FY2021-Q1Addition to the scope of consolidationAnnual report
「恩欧富塗料商貿(上海)有限公司, which had been an unconsolidated subsidiary through the previous consolidated fiscal year, has been included in the scope of consolidation from the first quarter of the current consolidated fiscal year because its materiality has increased.」
恩欧富塗料商貿(上海)有限公司 was included in the scope of consolidation from the first quarter of the current consolidated fiscal year because its materiality had increased. - FY2020Update to the number of affiliatesAnnual report
「The corporate group comprises the company, 32 subsidiaries, including 13 overseas subsidiaries, and 5 affiliates, none of which are overseas affiliates. It primarily conducts businesses related to functional chemicals, life sciences and explosives, as well as other business activities including transportation and real estate.」
The 3 core businesses remain unchanged, while the number of affiliates has been updated from 6 to 5. - FY2020-Q3RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Group, comprising the Company and its affiliated companies, during the cumulative third quarter under review. There were also no changes among the principal affiliated companies.」
There have been no material changes in the business portfolio centered on functional chemicals, life sciences and explosives, or in the number of principal affiliates. - FY2020-Q1RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Group, comprising the Company and its affiliated companies, during the cumulative first quarter under review. There were also no changes among the principal affiliated companies.」
There have been no material changes in the business portfolio centered on functional chemicals, life sciences and explosives, or in the number of principal affiliates. - FY2019Update to the number of companies in the corporate groupAnnual report
「The corporate group comprises the company, 32 subsidiaries, including 13 overseas subsidiaries, and 6 affiliates, none of which are overseas affiliates. It primarily conducts businesses related to functional chemicals, life sciences and explosives, as well as other business activities including transportation and real estate.」
The 3 core businesses remain unchanged, while the corporate group is described as comprising 32 subsidiaries, including 13 overseas subsidiaries. - FY2019-Q3RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Group, comprising the Company and its affiliated companies, during the cumulative third quarter under review. There were also no changes among the principal affiliated companies.」
There have been no material changes in the business portfolio centered on functional chemicals, life sciences and explosives, or in the number of principal affiliates. - FY2019-Q2RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Group, consisting of the Company and its affiliated companies, during the second quarter of the current consolidated cumulative period. There were also no changes among the principal affiliated companies.」
There have been no material changes in the business portfolio centered on functional chemicals, life sciences and explosives, or in the number of principal affiliates. - FY2019-Q1RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Group, comprising the Company and its affiliated companies, during the cumulative first quarter under review. There were also no changes among the principal affiliated companies.」
The company states that there have been no material changes in its business portfolio centered on functional chemicals, life sciences and explosives, or in its principal affiliates. - FY2018-Q3RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Group, comprising the Company and its affiliated companies, during the cumulative third quarter under review. There were also no changes among the principal affiliated companies.」
The company states that there have been no material changes in its business portfolio centered on functional chemicals, life sciences and explosives, or in its principal affiliates. - FY2018-Q2RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Group, consisting of the Company and its affiliated companies, during the second quarter of the current consolidated cumulative period. There were also no changes among the principal affiliated companies.」
The company states that there have been no material changes in its business portfolio centered on functional chemicals, life sciences and explosives, or in its principal affiliates. - FY2018-Q1RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Group, comprising the Company and its affiliated companies, during the cumulative first quarter under review. There were also no changes among the principal affiliated companies.」
There have been no material changes in the business portfolio centered on functional chemicals, life sciences and explosives, or in the number of principal affiliates. - FY2017Update to the number of overseas subsidiariesAnnual report
「The corporate group comprises the company, 34 subsidiaries, including 14 overseas subsidiaries, and 6 affiliates, none of which are overseas affiliates. It primarily conducts businesses related to functional chemicals, life sciences and explosives.」
The 3 core business areas remain functional chemicals, life sciences and explosives, while the number of overseas subsidiaries has been updated from 13 to 14. - FY2017-Q3RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Group, comprising the Company and its affiliated companies, during the cumulative third quarter under review. There were also no changes among the principal affiliated companies.」
There have been no material changes in the business portfolio centered on functional chemicals, life sciences and explosives, or in the number of principal affiliates. - FY2017-Q2RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Group, consisting of the Company and its affiliated companies, during the second quarter of the current consolidated cumulative period. There were also no changes among the principal affiliated companies.」
There have been no material changes in the business portfolio centered on functional chemicals, life sciences and explosives, or in the number of principal affiliates. - FY2017-Q1RestatedAnnual report
「There were no material changes in the nature of the businesses conducted by the Group, comprising the Company and its affiliated companies, during the cumulative first quarter under review. There were also no changes among the principal affiliated companies.」
The company states that there have been no material changes in its business portfolio centered on functional chemicals, life sciences and explosives, or in its principal affiliates. - FY2016First statedAnnual report
「The corporate group comprises the company, 34 subsidiaries, including 13 overseas subsidiaries, and 6 affiliates, none of which are overseas affiliates. It primarily conducts businesses related to functional chemicals, life sciences and explosives, as well as other business activities including transportation and real estate.」
The reportable segments comprise 3 businesses: functional chemicals, life sciences and explosives.